文献速递流行病学与生物统计基础与转化研究

生命最初1000天危险因素与儿童颈动脉内中膜厚度的系统综述与荟萃分析

Risk factors during first 1,000 days of life for carotid intima-media thickness in infants, children, and adolescents: A systematic review with meta-analyses.
PubMed 文献 · PLoS Med · 2020-11-23

该系统综述与荟萃分析纳入36项研究共7977名0-18岁参与者,评估生命最初1000天暴露与颈动脉内中膜厚度(CIMT)的关系。小于胎龄儿与CIMT增高相关(汇总SMD 0.40,95%CI 0.15-0.64,p=0.001),辅助生殖技术受孕和孕期吸烟暴露点估计值增高但无统计学意义,证据质量受限于高质量研究少和异质性高。

要点

  • 小于胎龄儿与儿童期CIMT增高相关,汇总SMD为0.40(95%CI 0.15-0.64)。
  • 辅助生殖技术受孕和孕期吸烟与CIMT的关联无统计学意义,估计精度低。
  • 仅12项(33%)研究在CIMT可靠性所有领域为较高质量,证据不确定性大。

核心结论

  • 生命最初1000天内的若干危险因素可能与儿童期CIMT增高相关。
  • 小于胎龄儿与CIMT增高的关联最为一致。
  • 辅助生殖技术受孕或孕期吸烟与CIMT的关联无统计学意义且估计不精确。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE和CENTRAL从建库至2019年3月。
  • 纳入34项观察性研究和2项干预性研究,共7977名0至18岁参与者。
  • 研究方案在PROSPERO注册(CRD42017075169)。

主要发现

  • 小于胎龄儿与CIMT增高相关:16项研究2570人,汇总SMD 0.40(95%CI 0.15-0.64,p=0.001),I2为83%。
  • 限制于CIMT测量质量较高的研究时该关联更强:3项研究461人,汇总SMD 0.64(95%CI 0.09-1.19,p=0.024),I2为86%。
  • 辅助生殖技术受孕与CIMT:3项研究323人,汇总SMD 0.78(95%CI -0.20至1.75,p=0.120),I2为94%。
  • 孕期吸烟暴露与CIMT:3项研究909人,汇总SMD 0.12(95%CI -0.06至0.30,p=0.205),I2为0%。
  • 出生时开始的营养干预研究未显示对CIMT有影响。

关键数值与推荐

  • 仅1项评估小于胎龄儿的研究在所有方法学领域被评为高质量。
  • 评估辅助生殖技术受孕或孕期吸烟的研究均无在所有方法学领域被评为高质量。
  • 仅12项(33%)研究在CIMT可靠性所有领域为较高质量。

临床怎么用

  • 小于胎龄儿可作为儿童期亚临床动脉粥样硬化风险评估的关注因素。
  • 辅助生殖技术受孕和孕期吸烟与CIMT的关联证据不精确,尚不足以据此推荐干预。
  • 现有证据不确定性大,需进一步高质量研究为心血管病原始预防干预提供依据。

局限性

  • 高质量研究数量少。
  • 样本量相对较小。
  • 研究间异质性高。
  • CIMT测量质量有限导致效应量不确定性大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The first 1,000 days of life, i.e., from conception to age 2 years, could be a critical period for cardiovascular health. Increased carotid intima-media thickness (CIMT) is a surrogate marker of atherosclerosis. We performed a systematic review with meta-analyses to assess (1) the relationship between exposures or interventions in the first 1,000 days of life and CIMT in infants, children, and adolescents; and (2) the CIMT measurement methods. METHODS AND FINDINGS: Systematic searches of Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica database (EMBASE), and Cochrane Central Register of Controlled Trials (CENTRAL) were performed from inception to March 2019. Observational and interventional studies evaluating factors at the individual, familial, or environmental levels, for instance, size at birth, gestational age, breastfeeding, mode of conception, gestational diabetes, or smoking, were included. Quality was evaluated based on study methodological validity (adjusted Newcastle-Ottawa Scale if observational; Cochrane collaboration risk of bias tool if interventional) and CIMT measurement reliability. Estimates from bivariate or partial associations that were least adjusted for sex were used for pooling data across studies, when appropriate, using random-effects meta-analyses. The research protocol was published and registered on the International Prospective Register of Systematic Reviews (PROSPERO; CRD42017075169). Of 6,221 reports screened, 50 full-text articles from 36 studies (34 observational, 2 interventional) totaling 7,977 participants (0 to 18 years at CIMT assessment) were retained. Children born small for gestational age had increased CIMT (16 studies, 2,570 participants, pooled standardized mean difference (SMD): 0.40 (95% confidence interval (CI): 0.15 to 0.64, p: 0.001), I2: 83%). When restricted to studies of higher quality of CIMT measurement, this relationship was stronger (3 studies, 461 participants, pooled SMD: 0.64 (95% CI: 0.09 to 1.19, p: 0.024), I2: 86%). Only 1 study evaluating small size for gestational age was rated as high quality for all methodological domains. Children conceived through assisted reproductive technologies (ART) (3 studies, 323 participants, pooled SMD: 0.78 (95% CI: -0.20 to 1.75, p: 0.120), I2: 94%) or exposed to maternal smoking during pregnancy (3 studies, 909 participants, pooled SMD: 0.12 (95% CI: -0.06 to 0.30, p: 0.205), I2: 0%) had increased CIMT, but the imprecision around the estimates was high. None of the studies evaluating these 2 factors was rated as high quality for all methodological domains. Two studies evaluating the effect of nutritional interventions starting at birth did not show an effect on CIMT. Only 12 (33%) studies were at higher quality across all domains of CIMT reliability. The degree of confidence in results is limited by the low number of high-quality studies, the relatively small sample sizes, and the high between-study heterogeneity. CONCLUSIONS: In our meta-analyses, we found several risk factors in the first 1,000 days of life that may be associated with increased CIMT during childhood. Small size for gestational age had the most consistent relationship with increased CIMT. The associations with conception through ART or with smoking during pregnancy were not statistically significant, with a high imprecision around the estimates. Due to the large uncertainty in effect sizes and the limited quality of CIMT measurements, further high-quality studies are needed to justify intervention for primordial prevention of cardiovascular disease (CVD).

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Epure AM, Rios-Leyvraz M, Anker D, et al. Risk factors during first 1,000 days of life for carotid intima-media thickness in infants, children, and adolescents: A systematic review with meta-analyses. PLoS Med. 2020. PMID: 33226997. doi:10.1371/journal.pmed.1003414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。